Literature DB >> 15242723

Aspirin and NSAID sensitivity.

Donald D Stevenson1.   

Abstract

Aspirin and the older nonsteroidal anti-inflammatory drugs (NSAIDs) that block cyclo-oxygenase-1 (COX-1) induce asthma attacks in patients with aspirin-exacerbated respiratory disease and urticaria in patients with chronic idiopathic urticaria. Weak inhibitors of COX-1, such as acetaminophen and salsalate, crossreact also but only with high doses of the drugs. Partial inhibitors of both COX-1 and COX-2, such as nimesulide and meloxicam, also cross-react but only at high drug doses. COX-2 inhibitors do not cross-react; however, all NSAIDs, including the selective COX-2 inhibitors, can sensitize patients and induce urticaria or anaphylaxis on next exposure to the drug.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242723     DOI: 10.1016/j.iac.2004.03.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  20 in total

Review 1.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

Review 2.  [Analgesic intolerance (AI). Key position of ENT physicians for early detection of this condition].

Authors:  U Förster; H Olze
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

3.  Aspirin attenuates the anti-inflammatory effects of theophylline via inhibition of cAMP production in mice with non-eosinophilic asthma.

Authors:  Hyung-Geun Moon; You-Sun Kim; Jun-Pyo Choi; Dong-Sic Choi; Chang Min Yoon; Seong Gyu Jeon; Yong Song Gho; Yoon-Keun Kim
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

Review 4.  Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.

Authors:  Joshua M Levy; Luke Rudmik; Anju T Peters; Sarah K Wise; Brian W Rotenberg; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2016-08-02       Impact factor: 3.858

5.  [Adaptive desensitization for acetylsalicylic acid hypersensitivity: A success story?].

Authors:  G Mühlmeier; R Hausch; H Maier
Journal:  HNO       Date:  2015-10       Impact factor: 1.284

6.  National Athletic Trainers' Association position statement: management of asthma in athletes.

Authors:  Michael G Miller; John M Weiler; Robert Baker; James Collins; Gilbert D'Alonzo
Journal:  J Athl Train       Date:  2005 Jul-Sep       Impact factor: 2.860

7.  Anaphylaxis to ibuprofen in a 12-year-old boy.

Authors:  Emily Kay; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2013-01-14

Review 8.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

Review 9.  Clinical Immunology Review Series: An approach to the patient with angio-oedema.

Authors:  S Grigoriadou; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

10.  Differential contribution of the CysLTR1 gene in patients with aspirin hypersensitivity.

Authors:  Seung-Hyun Kim; Eun-Mi Yang; Han-Jung Park; Young-Min Ye; Hyun-Young Lee; Hae-Sim Park
Journal:  J Clin Immunol       Date:  2007-07-20       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.